SCHEMBL29909710

SCHEMBL29909710

CNc1ccnc(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL445950 1.00 — —
SCHEMBL22896965 0.83 GRM5 (0.35) —
SCHEMBL23887607 0.81 SYK (0.42) —
SCHEMBL17601584 0.78 LMNA (0.43) —
SCHEMBL1782191 0.77 — —
SCHEMBL31205727 0.77 — —
SCHEMBL1774897 0.77 GAA (0.42) —
SCHEMBL1519145 0.77 TLR8 (0.42) —
SCHEMBL21550282 0.75 ESR1 (0.35) —
SCHEMBL20685774 0.75 MAPK14 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081305-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2022-11-02 — — EP disclosed
Send feedback